Elevated risk of colorectal adenoma with Helicobacter pylori-related chronic gastritis: A population-based case-control study

International Journal of Cancer

Volumn 129, Issue 11, 2011, Pages 2704-2711

  Inoue, Izumi ^a   Mukoubayashi, Chizu ^a   Yoshimura, Noriko ^b   Niwa, Tohru ^a   Deguchi, Hisanobu ^a   Watanabe, Mika ^a   Enomoto, Shotaro ^a   Maekita, Takao ^a   Ueda, Kazuki ^a   Iguchi, Mikitaka ^a   Yanaoka, Kimihiko ^a   Tamai, Hideyuki ^a   Arii, Kenji ^a   Oka, Masashi ^a   Fujishiro, Mitsuhiro ^b   Takeshita, Tatsuya ^a   Iwane, Masataka ^c   Mohara, Osamu ^c   Ichinose, Masao ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Wakayama Wellness Foundation   (Japan)

Author keywords

cancer risk; case control study; chronic atrophic gastritis; colorectal adenoma; pepsinogen

Indexed keywords

BACTERIUM ANTIBODY; CHOLESTEROL; PEPSINOGEN;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; CANCER RISK; CANCER SCREENING; CANCER STAGING; CHRONIC GASTRITIS; CIGARETTE SMOKING; COLON CARCINOGENESIS; COLONOSCOPY; COLORECTAL ADENOMA; CONTROLLED STUDY; DISEASE SEVERITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HYPERCHOLESTEROLEMIA; INDUSTRIAL WORKER; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADENOCARCINOMA; ADENOMA; ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; COLORECTAL NEOPLASMS; FOLLOW-UP STUDIES; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JAPAN; MALE; MIDDLE AGED; PROGNOSIS; QUESTIONNAIRES; RISK FACTORS; SURVIVAL RATE;

EID: 80053307349     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25931     Document Type: Article

References (50)

1. Whiting JL, Sigurdsson A, Rowlands DC, Hallissey MT, Fielding JWL,. The long term results of endoscopic surveillance of premalignant gastric lesions. Gut 2002; 50: 378-81. (Pubitemid 34161055)
2. Correa P,. Human gastric carcinogenesis: a multistep and multifactorial process-first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52: 6735-40. (Pubitemid 23006271)
3. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, Yoshikawa A, Yanaoka K, Arii K, Tamai H, Shimizu Y, Ichinose M, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004; 109: 138-43. (Pubitemid 38160674)
4. Konturek SJ, Konturek PC, Pienia̧żek P, Bielański W,. Role of Helicobacter pylori infection in extragastroduodenal disorders: introductory remarks. J Physiol Pharmacol 1999; 50: 683-94. (Pubitemid 30090004)
5. Shemesh E, Czerniak A, Pines A, Bat L,. Is there an association between gastric polyps and colonic neoplasms? Digestion 1989; 42: 212-6. (Pubitemid 19212476)
6. Shimizu Y, Kakei N, Wada T, Yahagi N, Kido M, Ishihama S, Tsukada S, Matsushima M, Ichinose M, Miki K, Kurokawa K, Takahashi K,. Two cases of early colorectal cancer associated with gastric adenoma detected by serum pepsinogen screening method. Adv Exp Med Biol 1995; 362: 149-54.
7. Eom BW, Lee H-J, Yoo M-W, Cho JJ, Kim WH, Yang H-K, Lee KU,. Synchronous and metachronous cancers in patients with gastric cancer. J Surg Oncol 2008; 98: 106-10.
8. Lee JH, Bae JS, Ryu KW, Lee JS, Park SR, Kim CG, Kook MC, Choi IJ, Kim YW, Park JG, Bae J-M,. Gastric cancer patients at high-risk of having synchronous cancer. World J Gastroenterol 2006; 12: 2588-92.
9. Statistics and Information Department, Minister's Secretariat, Ministry of Health, Labor and Welfare. Age-adjusted death rates by prefecture. Special report on vital statistics of Japan, 2008. Tokyo: Health and Welfare Statistics Association.
10. Ciccotosto GD, McLeish A, Hardy KJ, Shulkes A,. Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology 1995; 109: 1142-53.
11. Kanno T, Matsuki T, Oka M, Utsunomiya H, Inada K, Magari H, Inoue I, Maekita T, Ueda K, Enomoto S, Iguchi M, Ichinose M, et al. Gastric acid reduction leads to an alteration in lower intestinal microflora. Biochem Biophys Res Commun 2009; 381: 666-70.
12. Chen TS, Chang FY, Lee SD,. Serodiagnosis of Helicobacter pylori infection: comparison and correlation between enzyme-linked immunosorbent assay and rapid serological test results. J Clin Microbiol 1997; 35: 184-6.
13. Ichinose M, Miki K, Furihata C, Kageyama T, Hayashi R, Niwa H, Oka H, Matsushima T, Takahashi T,. Radioimmunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders. Clinica Chimica Acta 1982; 126: 183-91. (Pubitemid 13247380)
14. Ichinose M, Yahagi N, Oka M, Ikeda H, Miki K, Omata M,. Screening for gastric cancer in Japan. In:, Wu GY, Aziz K, eds. Cancer screening. Totowa, NJ: Humana Press, 2001. 255-68.
15. Yanaoka K, Oka M, Yoshimura N, Mukoubayashi C, Enomato S, Iguchi M, Magari H, Utsunomiya H, Tamai H, Arii K, Mohara O, Ichinose M, et al. Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males. Cancer Epidemiol Biomarkers Prev 2008; 17: 838-45. (Pubitemid 351536414)
16. Komine M,. Megaloblastic anemia. Int J Hematol 2000; 71 (Suppl. 1): 8.
17. Plebani M, Basso D, Cassaro M, Brigato L, Scrigner M, Toma A, Mario FD, Rugge M,. Helicobacter pylori serology in patients with chronic gastritis. Am J Gastroenterol 1996; 91: 954-8.
18. Mårdh E, Mårdh S, Mårdh B, Borch K,. Diagnosis of gastritis by means of a combination of serological analyses. Clin Chim Acta 2002; 320: 17-27. (Pubitemid 34450817)
19. Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Furihata C, Matsushima T, Takahashi K,. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987; 22: 133-41. (Pubitemid 17065789)
20. Meucci G, Tatarella M, Vecchi M, Ranzi ML, Biguzzi E, Beccari G, Clerici E, de Franchis R,. High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas. J Clin Gastroenterol 1997; 25: 605-7. (Pubitemid 28051595)
21. Breuer-Katschinski B, Nemes K, Marr A, Rump B, Leiendecker B, Breuer N, Goebell H,; Colorectal Adenoma Study Group. Helicobacter pylori and the risk of colonic adenomas. Digestion 1999; 60: 210-5. (Pubitemid 29221887)
22. Mizuno S, Morita Y, Inui T, Asakawa A, Ueno N, Ando T, Kato H, Uchida M, Yoshikawa T, Inui A,. Helicobacter pylori infection is associated with colon adenomatous polyps detected by high-resolution colonoscopy. Int J Cancer 2005; 117: 1058-9. (Pubitemid 41688585)
23. Fireman Z, Trost L, Kopelman Y, Segal A, Sternberg A,. Helicobacter pylori: seroprevalence and colorectal cancer. IMAJ 2000; 2: 6-9. (Pubitemid 30662117)
24. Shmuely H, Passaro D, Figer A, Niv Y, Pitlik S, Samra Z, Koren R, Yahav J,. Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol 2001; 96: 3406-10. (Pubitemid 34016668)
25. Fujimori S, Kishida T, Kobayashi T, Sekita Y, Seo T, Nagata K, Tatsuguchi A, Gudis K, Yokoi K, Tanaka N, Yamashita K, Sakamoto C, et al. Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women. J Gastroenterol 2005; 40: 887-93. (Pubitemid 41511530)
26. Jones M, Helliwell P, Pritchard C, Tharakan J, Mathew J,. Helicobacter pylori in colorectal neoplasms: is there an aetiological relationship? World J Surg Oncol 2007; 5: 51.
27. Machida-Montani A, Sasazuki S, Inoue M, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Hanaoka T, Tsugane S,. Atrophic gastritis, Helicobacter pylori, and colorectal cancer risk: a case-control study. Helicobacter 2007; 12: 328-32. (Pubitemid 47196338)
28. Iacopetta B,. Are there two sides to colorectal cancer? Int J Cancer 2002; 101: 403-8.
29. Thorburn CM, Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J,. Gastrin and colorectal cancer: a prospective study. Gastroenterology 1998; 115: 275-80. (Pubitemid 28363419)
30. Georgopoulos SD, Polymeros D, Triantafyllou K, Spiliadi C, Mentis A, Karamanolis DG, Ladas SD,. Hypergastrinemia is associated with increased risk of distal colon adenomas. Digestion 2006; 74: 42-6. (Pubitemid 44835691)
31. Penman ID, El-Omar E, Ardill JES, McGregor JR, Galloway DJ, O'Dwyer PJ, McColl KEL,. Plasma gastrin concentrations are normal in patients with colorectal neoplasia and unaltered following tumor resection. Gastroenterology 1994; 106: 1263-70. (Pubitemid 24129243)
32. Aly A, Shulkes A, Baldwin GS,. Gastrins, cholecystokinins and gastrointestinal cancer. Biochim Biophys Acta 2004; 1704: 1-10. (Pubitemid 38802994)
33. Moore WEC, Moore LH,. Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 1995; 61: 3203-7.
34. Kado S, Uchida K, Funabashi H, Iwata S, Nagata Y, Ando M, Onoue M, Matsuoka Y, Ohwaki M, Morotomi M,. Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor β chain and p53 double-knockout mice. Cancer Res 2001; 61: 2395-8. (Pubitemid 32685812)
35. Horie H, Kanazawa K, Okada M, Narushima S, Itoh K, Terada A,. Effects of intestinal bacteria on the development of colonic neoplasm: an experimental study. Eur J Cancer Prev 1999; 8: 237-45.
36. Howden CW, Hunt RH,. Relationship between gastric secretion and infection. Gut 1987; 28: 96-107. (Pubitemid 17231555)
37. Drasar BS, Shiner M, McLeod GM,. Studies on the intestinal flora: I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. Gastroenterology 1969; 56: 71-9.
38. Thorens J, Froehlich F, Schwizer W, Saraga E, Bille J, Gyr K, Duroux P, Nicolet M, Pignatelli B, Blum AL, Gonvers JJ, Fried M,. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomized double blind study. Gut 1996; 39: 54-59. (Pubitemid 26239105)
39. Evenepoel P, Claus D, Geypens B, Maes B, Hiele M, Rutgeerts P, Ghoos Y,. Evidence for impaired assimilation and increased colonic fermentation of protein, related to gastric acid suppression therapy. Aliment Pharmacol Ther 1998; 12: 1011-9. (Pubitemid 28454385)
40. Aarbakke J, Schjönsby H,. Value of urinary simple phenol and indican determinations in the diagnosis of the stagnant loop syndrome. Scand J Gastroenterol 1976; 11: 409-14.
41. Visek WJ,. Diet and cell growth modulation by ammonia. Am J Clin Nutr 1978; 31: 216-20.
42. Nakajima T, Enomoto S, Ushijima T,. DNA methylation: a marker for carcinogen exposure and cancer risk. Environ Health Prev Med 2008; 13: 8-15.
43. Hodge DR, Xiao W, Clausen PA, Heidecker G, Szyf M, Farrar WL,. Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells. J Biol Chem 2001; 276: 39508-11.
44. Giovannucci E, Colditz GA, Stampfer MJ,. A meta-analysis of cholecystectomy and risk of colorectal cancer. Gastroenterology 1993; 105: 130-41. (Pubitemid 23234028)
45. Pereira MA, Wang W, Kramer PM, Tao L,. DNA hypomethylation induced by non-genotoxic carcinogens in mouse and rat colons. Cancer Lett 2004; 212: 145-51. (Pubitemid 38997970)
46. Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H,. Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res 2005; 589: 47-65. (Pubitemid 40094591)
47. Le Veen HH, Le Veen EG, Le Veen RF,. Awakenings to the pathogenicity of urease and the requirement for continuous long-term therapy. Biomed Pharmacother 1994; 48: 157-66. (Pubitemid 24134722)
48. Clinton SK, Bostwick DG, Olson LM, Mangian HJ, Visek WJ,. Effects of ammonium acetate and sodium cholate on N-methyl-N′-nitro-N- nitrosoguanidine-induced colon carcinogenesis of rats. Cancer Res 1988; 48: 3035-9.
49. Sawada S, Shinchi K, Imanishi K,. Prevalence of colorectal adenomas in a healthy Japanese middle-aged male population. Scand J Gastroenterol 1998; 33: 783-84. (Pubitemid 28358067)
50. Renga M, Brandi G, Paganelli GM, Calabrese C, Papa S, Tosti A, Tomassetti P, Miglioli M, Biasco G,. Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia. Gut 1997; 41: 330-2. (Pubitemid 27428191)